-
公开(公告)号:US12224045B2
公开(公告)日:2025-02-11
申请号:US17638395
申请日:2020-08-25
Applicant: AMGEN INC.
Inventor: Cindy Ren , Mohan B. Boggara , Nitin Rathore , Behnam Partopour
Abstract: In a method for predicting a property of potential protein formulations, a set of formulation descriptors is classified as belonging to a specific one of a plurality of predetermined groups that each correspond to a different value range for a protein formulation property. Classifying the set of descriptors includes applying at least a first portion of the set of descriptors as inputs to a first machine learning model. The method also includes selecting, based on the classification, a second machine learning model from among multiple models corresponding to different groups. The method also includes predicting a value of the protein formulation property that corresponds to the set of descriptors, by applying at least a second portion of the set of formulation descriptors as inputs to the selected model. The method further includes causing the value of the protein formulation property to be displayed to a user and/or stored in a memory.
-
公开(公告)号:US20220293223A1
公开(公告)日:2022-09-15
申请号:US17638395
申请日:2020-08-25
Applicant: AMGEN INC.
Inventor: Cindy Ren , Mohan B. Boggara , Nitin Rathore , Behnam Partopour
Abstract: In a method for predicting a property of potential protein formulations, a set of formulation descriptors is classified as belonging to a specific one of a plurality of predetermined groups that each correspond to a different value range for a protein formulation property. Classifying the set of descriptors includes applying at least a first portion of the set of descriptors as inputs to a first machine learning model. The method also includes selecting, based on the classification, a second machine learning model from among multiple models corresponding to different groups. The method also includes predicting a value of the protein formulation property that corresponds to the set of descriptors, by applying at least a second portion of the set of formulation descriptors as inputs to the selected model. The method further includes causing the value of the protein formulation property to be displayed to a user and/or stored in a memory.
-
公开(公告)号:US20240316194A1
公开(公告)日:2024-09-26
申请号:US18574161
申请日:2022-06-29
Applicant: AMGEN INC.
IPC: A61K39/395 , A61K9/00 , A61K9/19 , A61K39/00 , A61K47/10 , A61K47/18 , A61K47/26 , C07K16/28 , C07K16/30
CPC classification number: A61K39/39591 , A61K9/0019 , A61K9/19 , A61K47/10 , A61K47/183 , A61K47/26 , C07K16/2809 , C07K16/3092 , A61K2039/505 , C07K2317/31 , C07K2317/94
Abstract: Described herein is a method comprising (a) reconstituting a lyophilized formulation comprising a polypeptide, a saccharide, a surfactant, and a buffer, with a diluent comprising an aromatic alcohol, a phenolic compound, or an amino acid with aromatic side chain, and (b) administering the reconstituted formulation to a subject in need thereof within 12 hours of reconstitution, wherein the polypeptide is a bispecific antibody construct, such as a bispecific antibody construct that binds human DLL3 and human CD3 and optionally comprises the amino acid sequence of SEQ ID NO: 75 and SEQ ID NO: 9.
-
-